Intelligent Infrastructures: InfraAI is designing AI-driven systems that manage themselves. By developing new building blocks and abstractions, these systems adapt in real time, optimize performance, ...

More lessons from the jagged frontiers of new technology Read more at straitstimes.com. Read more at straitstimes.com.

Vibe coding, like many other technological revolutions, started as a thing of wonder. Now we are seeing its large-scale application in building software and apps, and as a critical tool of business ...

Senior Director Paul Praveen Kumar Ashok’s peer-reviewed research charts a new course for enterprise ERP systems — from blockchain-enabled smart contracts and automated procurement workflows to ...

“AI may generate code faster than any human,” Guo said. “But the need to understand what code is doing has only intensified. AI generates code that may seem right, but it isn’t always reliable. You ...

OpenAI on Thursday confirmed a Wall ​Street Journal report that it plans ‌to fold its ChatGPT app, coding platform Codex and browser into a single desktop "superapp" to simplify user ​experience.

OpenAI will combine its web browser, ChatGPT app and Codex app into a singular desktop super app. Fidji Simo, OpenAI's CEO of Applications, will oversee the change with assistance from OpenAI ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Whether you choose Claude Code, Base44, Cursor, or Goose, here are a few ways solopreneurs can use vibe coding to grow their ...

OpenAI has made several recent acquisitions, including cybersecurity startup Promptfoo, and health-care technology startup Torch.

t has to prove that its integrated platform, team controls and now its own in-house models add enough value to justify sitting between developers and the model makers.

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.